SCHEMBL4704191

SCHEMBL4704191

CCc1cnc2c(OC)cccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 2/20 0.57
PARP1 P09874 1/20 0.55
NQO2 P16083 4/20 0.44
PDE10A Q9Y233 2/20 0.43
MCHR1 Q99705 1/20 0.42
LMNA P02545 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811070 0.86 HPGDS (0.56) HPGDSPARP1NQO2PDE10AMCHR1
SCHEMBL27741805 0.86 HPGDS (0.56) HPGDSPARP1NQO2PDE10AMCHR1
SCHEMBL13255540 0.83 HPGDS (0.54) HPGDSNQO2PDE10A
SCHEMBL9308505 0.82 PARP1 (0.53) HPGDSPARP1LMNANPC1RAB9A
SCHEMBL12020200 0.81 HPGDS (0.51) HPGDSNQO2PDE10ALMNANPC1
SCHEMBL9308502 0.80 PARP1 (0.51) HPGDSPARP1LMNANPC1RAB9A
Jineol Methyl Ether SCHEMBL8613544 0.78 HPGDS (0.62) HPGDSPARP1NQO2PDE10AMCHR1
SCHEMBL434888 0.78 HPGDS (0.62) HPGDSPARP1NQO2MCHR1LMNA
SCHEMBL5094347 0.78 PARP1 (0.59) PARP1MEN1KMT2APDE3BPDE3A
SCHEMBL6171961 0.78 PARP1 (0.59) PARP1LMNASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802594-B1 METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES UDC IRELAND LTD (IE) 2017-04-19 EP disclosed
EP-0952832-B1 QUINOLINE CARBOXAMIDES AS TNF INHIBITORS AND AS PDE-IV INHIBITORS DARWIN DISCOVERY LTD (GB) 2008-08-27 EP disclosed
CN-1148189-C Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors ������������� 2004-05-05 CN disclosed
EP-0952832-A1 QUINOLINE CARBOXAMIDES AS TNF INHIBITORS AND AS PDE-IV INHIBITORS Darwin Discovery Limited (GB) 1999-11-03 EP disclosed
CN-1219131-A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors DARWIN DISCOVERY CO LTD (GB) 1999-06-09 CN disclosed
US-5804588-A TREATING DISEASES THAT ARE MODULATED BY INHIBITION OF PHOSPHODIESTERASE IV OR TUMOUR NECROSIS FACTOR CHIROSCIENCE LIMITED (GB) 1998-09-08 US disclosed
WO-1997044036-A1 QUINOLINE CARBOXAMIDES AS TNF INHIBITORS AND AS PDE-IV INHIBITORS DARWIN DISCOVERY LIMITED (GB) 1997-11-27 WO disclosed
EP-0247277-B1 PROCESS FOR THE PREPARATION OF 5-ALKYLQUINOLINIC ACIDS AND MEANS FOR CARRYING OUT THIS PROCESS RÜTGERSWERKE AKTIENGESELLSCHAFT (DE) 1991-09-11 EP disclosed
EP-0247277-A2 Process for the preparation of 5-alkylquinolinic acids and means for carrying out this process RÜTGERSWERKE AKTIENGESELLSCHAFT (DE) 1987-12-02 EP disclosed